Percheron Therapeutics LimitedASX: PER

Appendix 4G and Corporate Governance Statement

· Issued by Percheron Therapeutics Limited via ASX

Filed with ASX ·

Rules 4.7.3 and 4.10.3 ASX Listing Rules Appendix 4G (current at 17/7/2020) Page 1 Appendix 4G Key to Disclosures Corporate Governance Council Principles and Recommendations Name of entity Percheron Therapeutics Limited ABN/ARBN Financial year ended: 41095060745 30 June...

View Attachment

6ix hasn’t read this filing yet.

Percheron Therapeutics Limited on 6ix

Earlier from Percheron Therapeutics

Later from Percheron Therapeutics

All Percheron Therapeutics news releases